Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.39 |
| ▸ | PDE4A | P27815 | 1/20 | 0.30 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11041165 | 1.00 | USP2 (0.39) | USP2SLCO1B1PDE4APTPN1 | |
| SCHEMBL15536079 | 0.88 | USP2 (0.35) | USP2SLCO1B1PTPN1 | |
| SCHEMBL17468431 | 0.87 | USP2 (0.38) | USP2SLCO1B1 | |
| SCHEMBL17201985 | 0.80 | USP2 (0.42) | USP2SLCO1B1PDE4A | |
| Phosphoric Acid SCHEMBL1696409 | 0.79 | USP2 (0.53) | USP2SLCO1B1PDE4A | |
| SCHEMBL19514770 | 0.76 | LMNA (0.42) | USP2SLCO1B1PDE4APTPN1 | |
| SCHEMBL17555601 | 0.76 | LMNA (0.42) | USP2SLCO1B1PDE4APTPN1 | |
| SCHEMBL7695502 | 0.76 | LMNA (0.42) | USP2SLCO1B1PDE4APTPN1 | |
| SCHEMBL27772430 | 0.76 | LMNA (0.42) | USP2SLCO1B1PDE4APTPN1 | |
| SCHEMBL9456987 | 0.76 | LMNA (0.42) | USP2SLCO1B1PDE4APTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119301264-A | Method for producing heparan sulfate, heparan sulfate and heparin in yeast | 根蒂斯精细化学品有限公司 | 2025-01-10 | — | — | CN | claimed |
| CN-118291553-A | Biosynthesis method of starch | 中国科学院天津工业生物技术研究所 | 2024-07-05 | — | — | CN | claimed |
| CN-117460835-A | Recombinant cells for the production of heparin precursors | 奇华顿股份有限公司 | 2024-01-26 | — | — | CN | claimed |
| CN-117460824-A | Recombinant cell for producing chondroitin | 奇华顿股份有限公司 | 2024-01-26 | — | — | CN | claimed |
| CN-117460821-A | Recombinant cell for producing hyaluronic acid | 奇华顿股份有限公司 | 2024-01-26 | — | — | CN | claimed |
| CN-116801892-A | Adipogenic cell compositions and methods | 旗舰创业股份有限公司 | 2023-09-22 | — | — | CN | claimed |
| CN-116096912-A | Production of a mixture of neutral nonfucosylated oligosaccharides by cells | 因比奥斯公司 | 2023-05-09 | — | — | CN | claimed |
| CN-120982519-A | Osthole pH response hydrogel targeting Ustilago virens AGM1 protein and preparation method thereof | 安顺学院 | 2025-11-21 | — | — | CN | disclosed |
| CN-119301264-A | Method for producing heparan sulfate, heparan sulfate and heparin in yeast | 根蒂斯精细化学品有限公司 | 2025-01-10 | — | — | CN | disclosed |
| CN-118922534-A | For producing sialylated oligosaccharides sugar sialyltransferases | 因比奥斯公司 | 2024-11-08 | — | — | CN | disclosed |
| CN-118414434-A | Production of alpha-1, 4-fucosylated compounds | 因比奥斯公司 | 2024-07-30 | — | — | CN | disclosed |
| CN-118401655-A | Sialyltransferase for producing sialylated oligosaccharides | 因比奥斯公司 | 2024-07-26 | — | — | CN | disclosed |
| CN-118291553-A | Biosynthesis method of starch | 中国科学院天津工业生物技术研究所 | 2024-07-05 | — | — | CN | disclosed |
| CN-114450417-A | Increased oligosaccharide production in yeast | 阿米瑞斯公司 | 2022-05-06 | — | — | CN | disclosed |
| US-20120308569-A1 | GENE PRODUCTS DIFFERENTIALLY EXPRESSED IN CANCEROUS CELLS | NOVARTIS VACCINES & DIAGNOSTICS, INC. (US) | 2012-12-06 | — | — | US | disclosed |
| US-8221983-B2 | Gene products differentially expressed in cancerous cells | NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) | 2012-07-17 | — | — | US | disclosed |
| US-20100233187-A1 | GENE PRODUCTS DIFFERENTIALLY EXPRESSED IN CANCEROUS CELLS | CHAN VIVIEN W | 2010-09-16 | — | — | US | disclosed |
| US-7700359-B2 | Gene products differentially expressed in cancerous cells | NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) | 2010-04-20 | — | — | US | disclosed |
| WO-2008143679-A2 | NUCLEIC ACIDS AND PROTEINS AND METHODS FOR MAKING AND USING THEM | VERENIUM CORPORATION (US) | 2008-11-27 | — | — | WO | disclosed |
| US-20070010469-A1 | Gene products differentially expressed in cancerous cells III | NOVARTIS VACCINES AND DIAGNOSTICS, INC. | 2007-01-11 | — | — | US | disclosed |